James Mullen
Patrimonio netto: 2 M $ in data 31/05/2026
Patrimonio netto: 2 M $ in data 31/05/2026
James C. Mullen è un uomo d'affari che è stato alla guida di 11 diverse aziende e attualmente occupa la posizione di presidente non esecutivo di Percivia LLC, presidente, presidente e amministratore delegato di Editas Medicine, Inc. e amministratore delegato di DPx Holdings BV. È anche nel consiglio di Thermo Fisher Scientific, Inc. e The Rivers School Corp. e membro del Biomedical Sciences Careers Program, Inc. In passato James C. Mullen ha occupato la posizione di presidente esecutivo presso Vicarius Pharma AG, presidente, amministratore delegato e direttore presso Biogen, Inc. Direttore presso Biogen Idec, Inc. (North Carolina) e Presidente presso Biogen Idec New Ventures, Inc. (entrambe sono filiali di Biogen, Inc.), presidente di Torque Therapeutics, Inc., amministratore delegato e direttore non indipendente di Patheon, Inc., amministratore delegato e direttore esecutivo di Patheon NV, direttore di GlaxoSmithKline LLC e presidente di Biotechnology Innovation Organization. Ha ricevuto un MBA dalla Villanova University e una laurea presso il Rensselaer Polytechnic Institute.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 28/02/2026 | 3.393 ( 0% ) | 2 M $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
Biomedical Sciences Careers Program, Inc. | Corporate Officer/Principal | - |
Percivia LLC
Percivia LLC Miscellaneous Commercial ServicesCommercial Services Provides research for developing vaccine and recombinant protein products | Presidente | - |
The Rivers School Corp.
The Rivers School Corp. Other Consumer ServicesConsumer Services Functions as a College/University | Direttore/Membro del Consiglio | - |
DPx Holdings BV
DPx Holdings BV Drugstore ChainsRetail Trade Provides pharmaceutical services, fine chemicals and proprietary products and technologies | Amministratore Delegato | - |
| Società | Posizione | Fine |
|---|---|---|
| THERMO FISHER SCIENTIFIC, INC. | Direttore/Membro del Consiglio | 20/05/2026 |
| EDITAS MEDICINE, INC. | Amministratore Delegato | 01/06/2022 |
| INSULET CORPORATION | Direttore/Membro del Consiglio | 28/01/2019 |
Torque Therapeutics, Inc.
Torque Therapeutics, Inc. BiotechnologyHealth Technology Develops immunotherapies to address cancers | Presidente | 25/01/2019 |
| PATHEON N.V. | Amministratore Delegato | 29/08/2017 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 19 |
|---|---|
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Revvity, Inc.
Revvity, Inc. Medical SpecialtiesHealth Technology Manufactures and distributes reagents, analytical instruments and develops software | Health Technology |
Patheon, Inc.
Patheon, Inc. Pharmaceuticals: MajorHealth Technology Provides drug development and manufacturing services | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Rensselaer Polytechnic Institute
Rensselaer Polytechnic Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Villanova University
Villanova University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Insulet Corp.
Insulet Corp. Medical SpecialtiesHealth Technology Manufactures, develops and markets insulin infusion systems | Health Technology |
Biogen Idec New Ventures, Inc.
Biogen Idec New Ventures, Inc. Investment ManagersFinance Biogen Idec New Ventures' strategy is to select investments in companies developing innovative human therapeutic products or technologies that will drive product discovery and development more efficiently. Their specific areas of interest are companies in Biogen Idec's current therapeutic areas of neurology, oncology and immunology/inflammation, but they also seek opportunities outside these areas that fit their strategies for longer-term growth. The firm invests at all stages of development; most of their investments are in early-stage companies. They also look for investment opportunities where they can leverage their parent's resources and scientific and development expertise to support these investments. | Finance |
Thermo Fisher Scientific, Inc.
Thermo Fisher Scientific, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and markets analytical and environment monitoring instruments | Health Technology |
Percivia LLC
Percivia LLC Miscellaneous Commercial ServicesCommercial Services Provides research for developing vaccine and recombinant protein products | Commercial Services |
Biogen Idec, Inc. (North Carolina)
Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Biomedical Sciences Careers Program, Inc. | |
The Rivers School Corp.
The Rivers School Corp. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Health Technology |
Editas Medicine, Inc.
Editas Medicine, Inc. BiotechnologyHealth Technology Manufactures gene editing medicines | Health Technology |
DPx Holdings BV
DPx Holdings BV Drugstore ChainsRetail Trade Provides pharmaceutical services, fine chemicals and proprietary products and technologies | Retail Trade |
Patheon NV
Patheon NV Pharmaceuticals: MajorHealth Technology Provides pharmaceutical development and manufacturing services | Health Technology |
Torque Therapeutics, Inc.
Torque Therapeutics, Inc. BiotechnologyHealth Technology Develops immunotherapies to address cancers | Health Technology |
Vicarius Pharma AG
Vicarius Pharma AG Miscellaneous Commercial ServicesCommercial Services Provides research and development services for pharmaceutical, biotech and medical companies | Commercial Services |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale